Evidence brief · Supplement
Nicotinamide Riboside for Blood NAD+
Evidence grade A — Reliably raised
- Overall grade
- Grade A
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade A — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- Blood NAD+Evidence grade A
Reliably raised
Moderatehigh
The evidence in words
The verdict
For blood nad+, Nicotinamide Riboside earns evidence grade A (moderate effect, high consistency) — there is real evidence here. Reliably raised
How it might work
It is converted to NAD+, aiming to restore the age-related decline in this central coenzyme.
How to use it
300–1,000 mg/day.
Safety & cautions
Well tolerated in trials to a year.
Bottom line
The most-vetted NAD+ booster for safety, but the clinical payoff still hasn't shown up. Fine to trial, don't expect miracles.
How it is used
As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.
- Standard
- 300–1,000 mg/day.
Goes with
- Nicotinamide RibosideRead the full Nicotinamide Riboside monographEvidence grade C
Related reading
Entries that share this one's tags or conditions.
- NMN for Blood NAD+Evidence grade B — Reliably raisedEvidence grade B
- Nicotinamide Riboside for Physical / metabolic functionEvidence grade C — InconsistentEvidence grade C
- NMN for Physical function / insulin sensitivityEvidence grade C — Early, smallEvidence grade C
- Nicotinamide Riboside: dosage and how to take it300–1,000 mg/day.Evidence grade C
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.